Status:

COMPLETED

HCV-HIV Co-infected Patient Cohort in Thailand

Lead Sponsor:

Institut de Recherche pour le Developpement

Collaborating Sponsors:

Ministry of Health, Thailand

Conditions:

Hepatitis C Infection

HIV

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This is a study of HCV treatment using the standard regimen of pegylated-interferon plus ribavirin in HIV co-infected patients participating in the PHPT cohort study. The treatment will be implemented...

Detailed Description

Study Population Screening: HIV infected patients with a positive anti-HCV test will be approached for screening if they are at least 18 years old, participate in the PHPT cohort study, have evidence ...

Eligibility Criteria

Inclusion

  • Evidence of chronic HCV infection for at least 6 months before study entry (at least one detectable HCV viral load, i.e. ≥17 IU/mL, with an antibody test positive at least 6 months before the HCV RNA load result)
  • Fibrosis Stage F2-3-4 determined by transient elastography (Fibroscan or other similar equipment). During the first part of the study, priority will be given to patients with Fibrosis Stage F2-3.
  • Negative pregnancy test (on the day of inclusion).

Exclusion

  • Anemia and thrombocytopenia
  • Severe liver damage, advanced stage cirrhosis or cancer
  • Uncontrolled diabetes, Uncontrolled thyroid dysfunction
  • Retinopathy
  • Creatinine clearance \<50 mL/min (Cockcroft)
  • Disease associated with the immune system
  • Significant heart problems
  • Severe neuropsychiatric conditions Contra-indication to study treatment (including pregnancy or lack of effective contraception in the participant or female partner)
  • Other exclusion criteria related to the use of ribavirin and peg-interferon
  • Any conditions that, in the investigator's judgment, may compromise the follow up.

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2018

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT02247440

Start Date

August 1 2014

End Date

January 1 2018

Last Update

June 3 2019

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Sanpatong Hospital

San Pa Tong, Chiang Mai, Thailand, 50120

2

Nakornping Hospital

Chiang Mai, Thailand, 50180

3

Chiangrai Prachanukroh Hospital

Chiang Rai, Thailand, 57000

4

Chonburi Hospital

Chon Buri, Thailand, 20000

HCV-HIV Co-infected Patient Cohort in Thailand | DecenTrialz